The purpose of the Translational Imaging Core (TIC) for the proposed Kidney Cancer SPORE program is to provide investigators in this program with the technical expertise to perform high quality imaging experiments; to facilitate standardized imaging protocols that allow for easier and more reliable correlation between results of pre-clinical and clinical imaging experiments; to provide consistent expertise in the interpretation of imaging results; and to facilitate storage and retrieval of imaging data. The primary functions of the TIC are to perform magnetic resonance (MR) imaging and Positron Emission Tomography (PET) assessments of response to treatments in patients with renal cell carcinoma (RCC), to provide imaging methods for mechanistic assessment of targeted therapy in tumor models, and to provide an image-based platform to guide and optimize tissue procurement through an appreciation of tumor traits and heterogeneity. Multiple MR imaging and PET techniques will be analyzed in order to maximize the chances of detecting subtle changes in tumor characteristics and response to therapy. Imaging data will be integrated with data generated from the Biospecimen and Pathology Resources (CORE B) and the Data Analytics (CORE C) cores into the Kidney Cancer Explorer (accessible through the web portal http://qbrc.swmed.edu/projects/kidneyspore/) to ensure SPORE investigators have a unified view of these data. Lastly, the TIC will provide a ?one stop shop? solution to SPORE investigators for imaging data storage and analysis both for pre-clinical experiments and human clinical trials with an integrated web- based Picture Archive and Communication Systems (PACS) and a software solution for image an alysis. The efforts of the TIC will translate into the development of quantitative imaging protocols that are readily available for use in clinical practice. These imaging protocols will be applicable at other institutions and will generate data that is currently not available in patients with kidney cancer. If successful, these protocols will allow for a change in the current management of kidney cancer patients that is based on quantitative, objective imaging data.

Public Health Relevance

The Translational Imaging Core (TIC) will offer novel quantitative magnetic resonance (MR) imaging techniques and Positron Emission Tomography (PET) with a variety of radiotracers to SPORE investigators for the noninvasive characterization of renal cell carcinoma in animal models and patients and for assessing the response to targeted therapies. A sophisticated protocol to co -register MR images and tumor specimens will allow for targeted tissue procurement informed by MR features detected in vivo. The TIC will provide a web-based centralized archive and image analysis capabilities for all imaging acquired in SPORE projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA196516-02
Application #
9359358
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Hruszkewycz, Andrew M
Project Start
Project End
Budget Start
2017-08-01
Budget End
2018-07-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Kay, Fernando U; Canvasser, Noah E; Xi, Yin et al. (2018) Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass Histology. Radiology 287:543-553
Chen, Xi; Zhou, Zhiguo; Hannan, Raquibul et al. (2018) Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model. Phys Med Biol 63:215008
Puertollano, Rosa; Ferguson, Shawn M; Brugarolas, James et al. (2018) The complex relationship between TFEB transcription factor phosphorylation and subcellular localization. EMBO J 37:
Chen, Kenneth S; Stroup, Emily K; Budhipramono, Albert et al. (2018) Mutations in microRNA processing genes in Wilms tumors derepress the IGF2 regulator PLAG1. Genes Dev 32:996-1007
O'Kelly, Devin; Zhou, Heling; Mason, Ralph P (2018) Tomographic breathing detection: a method to noninvasively assess in situ respiratory dynamics. J Biomed Opt 23:1-6
Wang, Xinzeng; Pirasteh, Ali; Brugarolas, James et al. (2018) Whole-body MRI for metastatic cancer detection using T2 -weighted imaging with fat and fluid suppression. Magn Reson Med 80:1402-1415
Courtney, Kevin D; Infante, Jeffrey R; Lam, Elaine T et al. (2018) Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2? Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma. J Clin Oncol 36:867-874
Krajewski, Katherine M; Pedrosa, Ivan (2018) Imaging Advances in the Management of Kidney Cancer. J Clin Oncol :JCO2018791236
Carbone, Michele; Amelio, Ivano; Affar, El Bachir et al. (2018) Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine. Cell Death Differ 25:1885-1904
Kay, Fernando U; Pedrosa, Ivan (2018) Imaging of Solid Renal Masses. Urol Clin North Am 45:311-330

Showing the most recent 10 out of 28 publications